Literature DB >> 437845

Synthetic peptide chemotactic factors for neutrophils: the range of active peptides, their efficacy and inhibitory activity, and susceptibility of the cellular response to enzymes and bacterial toxins.

P C Wilkinson.   

Abstract

The chemotactic activity for neutrophil leucocytes of twenty-six peptides of varied sequence, of which the majority were N-formylated, was assessed by determining the concentration at which each was maximally active and the efficacy of each peptide at that concentration. These two measures of activity did not correlate with one another. Many formylated peptides with a wide variety of sequences were active. Of these, the formyl-methionyl peptides had highest efficacy, but many other peptides were active at concentrations as low as the formyl-methionyl tripeptides. Unrelated peptides, viz formyl-methionyl-leucyl-phenylalanine, acetyl-tri-alanine, formyl-tri--phenyla-lanine, cross-inhibit the cells' response to one another, and this inhibition is reversible. Inhibition is prevented if the cells are incubated throughout the experiment in levamisole or A23187. These experiments suggest that the leucocyte peptide receptor is capable of binding many ligands, and that activation of a response is not solely a function of binding affinity. They exclude a strict steric specificity for binding. Chemotactic responses to formylated peptides were shown to be reduced in cells pretreated with perfringolysin, a bacterial cholesterol-binding toxin, and with phospholipase C. Trypsin and pronase also reduced these responses when used at 500 micrograms per 10(6) cells but not at lower doses.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437845      PMCID: PMC1457588     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Exocytosis in human polymorphonuclear leukocytes induced by A 23187 and calcium.

Authors:  G Zabucchi; M R Soranzo; F Rossi
Journal:  FEBS Lett       Date:  1975-06-01       Impact factor: 4.124

2.  Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement.

Authors:  I Goldstein; S Hoffstein; J Gallin; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

3.  Studies on extracellular proteins from Staphylococcus aureus. VI. Production and purification of -haemolysin in large scale.

Authors:  T Wadström; R Möllby
Journal:  Biochim Biophys Acta       Date:  1971-07-21

4.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

5.  Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.

Authors:  S Aswanikumar; B Corcoran; E Schiffmann; A R Day; R J Freer; H J Showell; E L Becker
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

6.  Binding of protein chemotactic factors to the surfaces of neutrophil leukocytes and its modification with lipid-specific bacterial toxins.

Authors:  P C Wilkinson; R B Allan
Journal:  Mol Cell Biochem       Date:  1978-06-15       Impact factor: 3.396

7.  Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competitive antagonist.

Authors:  J T O'Flaherty; H J Showell; D L Kreutzer; P A Ward; E L Becker
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

9.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors.

Authors:  S H Zigmond
Journal:  J Cell Biol       Date:  1977-11       Impact factor: 10.539

View more
  14 in total

1.  Relations between Fc receptor function and locomotion in human lymphocytes.

Authors:  J M Shields; P C Wilkinson
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

2.  Chemotactic response of human monocytes to pentapeptide analog derived from immunodeficiency virus protein gp 120.

Authors:  S Spisani; R Gavioli; A L Giuliani; T Cavalletti; M Marastoni; G Balboni; S Salvadori; R Tomatis; S Traniello
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

3.  Response of human neutrophils to formyl-peptide modified at the terminal amino and carboxyl groups.

Authors:  S Spisani; T Cavalletti; R Gavioli; A Scatturin; G Vertuani; S Traniello
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

4.  Two neutrophil populations in human blood with different chemotactic activities: separation and chemoattractant binding.

Authors:  L Harvath; E J Leonard
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.

Authors:  B J McEwen; B P Wilcock; P Eyre
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

6.  Feline polymorphonuclear leukocytes respond chemotactically to leukotriene B4 and activated serum but not to F-Met-Leu-Phe.

Authors:  G D Gray; G M Ohlmann; D R Morton; R G Schaub
Journal:  Agents Actions       Date:  1986-06

7.  Prevention of neutrophil chemotactic deactivation by ascorbic acid.

Authors:  F Patrone; F Dallegri; G Lanzi; C Sacchetti
Journal:  Br J Exp Pathol       Date:  1980-10

Review 8.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

9.  Human neutrophil peptide receptors: mobilization mediated by phospholipase C.

Authors:  R D Nelson; V D Fiegel; D E Chenoweth
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

10.  Cytotaxin receptors of neutrophils: evidence that F-methionyl peptides and pepstatin share a common receptor.

Authors:  R D Nelson; S K Ackerman; V D Fiegel; M P Bauman; S D Douglas
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.